Nanox (NASDAQ: NNOX) announced on September 11, 2026, a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. Under the agreement, SOLME will oversee marketing, distribution, installation, training, and ongoing technical support in Costa Rica, where it is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services.
Commercialization will follow applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. Costa Rica represents Nanox's third Latin American market this year, following Argentina and Peru. This expansion underscores Nanox's commitment to driving the world's transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
The Nanox ecosystem combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care. The Nanox.ARC is a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability. Other components include Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. The company's vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
For investors and industry observers, this agreement signals Nanox's continued efforts to penetrate emerging markets where access to advanced medical imaging may be limited. The partnership with SOLME, a registered supplier to CCSS, could facilitate adoption within Costa Rica's public healthcare system, potentially improving diagnostic capabilities and patient care. As Nanox expands its footprint in Latin America, it may face regulatory and operational challenges, but successful implementation could serve as a model for other regions. The full press release can be viewed at https://ibn.fm/C77lJ, and the latest news and updates relating to NNOX are available in the company's newsroom at https://ibn.fm/NNOX.
